Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | THE-0504 |
| Synonyms | |
| Therapy Description |
THE-0504 is a nanomedicine comprising an engineered version of human ferritin heavy chain entrapping the topoisomerase I inhibitor Genz-644282, which potentially induces tumor cell killing and inhibits tumor growth (PMID: 33092088). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| THE-0504 | THE0504|THE 0504 | THE-0504 is a nanomedicine comprising an engineered version of human ferritin heavy chain entrapping the topoisomerase I inhibitor Genz-644282, which potentially induces tumor cell killing and inhibits tumor growth (PMID: 33092088). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07646106 | Phase I | THE-0504 | THE-0504 in Patients With Solid Tumors | Recruiting | ITA | 0 |